Literature DB >> 10784546

Drug treatment in heart failure.

E Lonn1, R McKelvie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10784546      PMCID： PMC1127584          DOI： 10.1136/bmj.320.7243.1188

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  20 in total

Review 1.  Anti-ischaemic effects of ACE inhibitors: review of current clinical evidence and ongoing clinical trials.

Authors:  S Yusuf; E Lonn
Journal:  Eur Heart J       Date:  1998-09       Impact factor: 29.983

2.  Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials.

Authors:  P Lechat; M Packer; S Chalon; M Cucherat; T Arab; J P Boissel
Journal:  Circulation       Date:  1998-09-22       Impact factor: 29.690

3.  The effect of digoxin on mortality and morbidity in patients with heart failure.

Authors: 
Journal:  N Engl J Med       Date:  1997-02-20       Impact factor: 91.245

Review 4.  Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management.

Authors:  B M Massie; N B Shah
Journal:  Am Heart J       Date:  1997-06       Impact factor: 4.749

5.  The treatment of heart failure. Task Force of the Working Group on Heart Failure of the European Society of Cardiology.

Authors: 
Journal:  Eur Heart J       Date:  1997-05       Impact factor: 29.983

6.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Authors:  Salim Yusuf; Bertram Pitt; Clarence E Davis; William B Hood; Jay N Cohn
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

7.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

8.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

Authors: 
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

9.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

10.  A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.

Authors:  R DiBianco; R Shabetai; W Kostuk; J Moran; R C Schlant; R Wright
Journal:  N Engl J Med       Date:  1989-03-16       Impact factor: 91.245
View more
  6 in total

1.  Role of spironolactone in heart failure should be emphasised.

Authors:  J Mapstone; B Houston; M Gogarty
Journal:  BMJ       Date:  2000-09-16

Review 2.  Metoprolol: a review of its use in chronic heart failure.

Authors:  A Prakash; A Markham
Journal:  Drugs       Date:  2000-09       Impact factor: 9.546

3.  A novel approach for assessing cardiac fibrosis using label-free second harmonic generation.

Authors:  Tamara P Martin; Greg Norris; Gail McConnell; Susan Currie
Journal:  Int J Cardiovasc Imaging       Date:  2013-08-07       Impact factor: 2.357

4.  Women with heart failure are at high psychosocial risk: a systematic review of how sex and gender influence heart failure self-care.

Authors:  Jody R Thomas; Alexander M Clark
Journal:  Cardiol Res Pract       Date:  2011-03-06       Impact factor: 1.866

5.  Formulation and development of novel control release transdermal patches of carvedilol to improve bioavailability for the treatment of heart failure.

Authors:  Long Mo; Guijing Lu; Xiping Ou; Dongsheng Ouyang
Journal:  Saudi J Biol Sci       Date:  2021-08-31       Impact factor: 4.219

6.  Ethanol Extract of Lepidium apetalum Seed Elicits Contractile Response and Attenuates Atrial Natriuretic Peptide Secretion in Beating Rabbit Atria.

Authors:  Seung Ju Kim; Hye Yoom Kim; Yun Jung Lee; Hao Zhen Cui; Ji Yeon Jang; Dae Gill Kang; Ho Sub Lee
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-29       Impact factor: 2.629
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.